{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:15:53Z","timestamp":1791353753557,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":641,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/jto.0000000000000070","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T07:37:38Z","timestamp":1391499458000},"page":"345-354","source":"Crossref","is-referenced-by-count":39,"title":["RANKL Inhibition Blocks Osteolytic Lesions and Reduces Skeletal Tumor Burden in Models of Non\u2013Small-Cell Lung Cancer Bone Metastases"],"prefix":"10.1016","volume":"9","author":[{"given":"Robert E.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon C.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tometsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Dougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0000000000000070_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/JTO.0b013e31819518fc","article-title":"Prevention and management of bone metastases in lung cancer: a review","volume":"4","author":"Al Husaini","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0000000000000070_bib2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0000000000000070_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1097\/JTO.0000000000000070_bib4","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2001.19.15.3562","article-title":"Biology of osteoclast activation in cancer","volume":"19","author":"Roodman","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000070_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1097\/JTO.0000000000000070_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1097\/JTO.0000000000000070_bib7","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/JTO.0b013e318229421f","article-title":"OPG\/RANKL\/RANK pathway as a therapeutic target in cancer","volume":"6","author":"McGrath","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0000000000000070_bib8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ijc.23625","article-title":"Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases","volume":"123","author":"Bu","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1097\/JTO.0000000000000070_bib9","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1101\/gad.1824809","article-title":"ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis","volume":"23","author":"Lu","year":"2009","journal-title":"Genes Dev"},{"key":"10.1097\/JTO.0000000000000070_bib10","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1097\/JTO.0000000000000070_bib11","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1359\/jbmr.060706","article-title":"Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration","volume":"21","author":"Feeley","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1097\/JTO.0000000000000070_bib12","first-page":"4432","article-title":"Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis","volume":"61","author":"Morony","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0000000000000070_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10585-006-9008-z","article-title":"The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice","volume":"23","author":"Tannehill-Gregg","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"10.1097\/JTO.0000000000000070_bib14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI11685","article-title":"Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone","volume":"107","author":"Zhang","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1097\/JTO.0000000000000070_bib15","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.bone.2011.03.687","article-title":"Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone","volume":"48","author":"Li","year":"2011","journal-title":"Bone"},{"key":"10.1097\/JTO.0000000000000070_bib16","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000070_bib17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","article-title":"Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study","volume":"7","author":"Scagliotti","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1097\/JTO.0000000000000070_bib18","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1158\/1535-7163.MCT-08-0046","article-title":"RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis","volume":"7","author":"Miller","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0000000000000070_bib19","first-page":"37","article-title":"Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells","volume":"59","author":"Stocking","year":"2009","journal-title":"Comp Med"},{"key":"10.1097\/JTO.0000000000000070_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10585-007-9127-1","article-title":"Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis","volume":"25","author":"Canon","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1097\/JTO.0000000000000070_bib21","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1089\/hum.1996.7.12-1405","article-title":"Episomal vectors rapidly and stably produce high-titer recombinant retrovirus","volume":"7","author":"Kinsella","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1097\/JTO.0000000000000070_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1097\/JTO.0000000000000070_bib23","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/cncr.20308","article-title":"Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial","volume":"100","author":"Rosen","year":"2004","journal-title":"Cancer"},{"key":"10.1097\/JTO.0000000000000070_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2007.03.013","article-title":"Skeletal metastases in non-small cell lung cancer: a retrospective study","volume":"57","author":"Tsuya","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0000000000000070_bib25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1078-0432.CCR-10-2507","article-title":"Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL\/RANK\/OPG pathway in tumorigenesis and metastasis","volume":"18","author":"Dougall","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0000000000000070_bib26","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/JCO.2012.46.9270","article-title":"New pathologic classification of lung cancer: relevance for clinical practice and clinical trials","volume":"31","author":"Travis","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000070_bib27","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1210\/endo.141.6.7518","article-title":"Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro","volume":"141","author":"Li","year":"2000","journal-title":"Endocrinology"},{"key":"10.1097\/JTO.0000000000000070_bib28","first-page":"2572","article-title":"Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy","volume":"61","author":"Oyajobi","year":"2001","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0000000000000070_bib29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1097\/JTO.0000000000000070_bib30","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0000000000000070_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10549-012-2222-2","article-title":"RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model","volume":"135","author":"Canon","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1097\/JTO.0000000000000070_bib32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jcb.23009","article-title":"RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation","volume":"112","author":"Chen","year":"2011","journal-title":"J Cell Biochem"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415302161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415302161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T22:25:24Z","timestamp":1538864724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415302161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1556086415302161"],"URL":"https:\/\/doi.org\/10.1097\/jto.0000000000000070","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}